Jiangsu Recbio Technology Co., Ltd. — Proxy Solicitation & Information Statement 2022

Jul 28, 2022

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this notice, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this notice.

==> picture [111 x 34] intentionally omitted <==

Jiangsu Recbio Technology Co., Ltd. 江蘇瑞科生物技術股份有限公司

(a joint stock company incorporated in the People’s Republic of China with limited liability)

(Stock code: 2179)

NOTICE OF H SHARE CLASS MEETING

NOTICE IS HEREBY GIVEN THAT the 2022 first H share class meeting (the “ H Share Class Meeting ”) of Jiangsu Recbio Technology Co., Ltd. (the “ Company ”) will be held on Monday, August 15, 2022, immediately after the conclusion or any adjourned meeting of the 2022 first extraordinary general meeting and the 2022 first class meeting for holders of domestic shares and unlisted foreign shares of the Company at Conference Room, 3/F, Building G29, Standard Plant, China Medical City Phase 6, Medical High-tech District, Taizhou City, Jiangsu Province, the People’s Republic of China for the following purposes:

SPECIAL RESOLUTIONS

1. To consider and approve the resolution on the application for “full circulation” of unlisted Shares of the Company;

2. To consider and approve the resolution on the authorization granted to the Board of Directors and its delegated persons to deal with matters related to the application for “full circulation” of unlisted Shares of the Company.

By order of the Board Jiangsu Recbio Technology Co., Ltd. Dr. LIU Yong Chairman

Jiangsu Province, the PRC July 29, 2022

– 1 –

Notes:

1. All resolutions at the H Share Class Meeting will be taken by poll (except where the chairman decides to allow a resolution relating to a procedural or administrative matter to be voted on by a show of hands) pursuant to the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited. The results of the poll will be published on the websites of the Company at www.recbio.cn and Hong Kong Exchanges and Clearing Limited at www.hkexnews.hk after the H Share Class Meeting.

2. Any Shareholder entitled to attend and vote at the H Share Class Meeting convened by the above notice is entitled to appoint one or more proxies to attend and vote instead of him/her. A proxy need not be a Shareholder of the Company.

3. In order to be valid, the instrument appointing a proxy together with the power of attorney or other authority, if any, under which it is signed, or a notarially certified copy of such power of attorney or authority, must be completed and returned to the H Share Registrar of the Company, Computershare Hong Kong Investor Services Limited, at 17M Floor, Hopewell Centre, 183 Queen’s Road East, Wanchai, Hong Kong, at least 24 hours before the H Share Class Meeting (i.e. before 10:00 a.m. August 14, 2022) or any adjourned meeting thereof. Completion and return of the form of proxy will not preclude a Shareholder from attending and voting at the H Share Class Meeting or any adjourned meeting thereof should he/she so wish.

4. For the purpose of determining the list of holders of H Shares who are entitled to attend the H Share Class Meeting, the H Share Register of members of the Company will be closed from Saturday, July 16, 2022 to Monday, August 15, 2022, both days inclusive, during which period no transfer of H Shares will be registered. In order to be eligible to attend and vote at the H Share Class Meeting, unregistered holders of the H Shares shall ensure all transfer documents accompanied by the relevant share certificates must be lodged with the Company’s H Share Registrar, Computershare Hong Kong Investor Services Limited at Shops 1712-1716, 17th Floor, Hopewell Centre, 183 Queen’s Road East, Wanchai, Hong Kong not later than 4:30 p.m. on Friday, July 15, 2022 for registration.

5. In case of joint Shareholders, the vote of the senior joint Shareholder who tenders a vote, whether in person or by proxy, will be accepted to the exclusion of the votes of the other joint Shareholder(s) and for this purpose, seniority will be determined by the order in which the names stand in the register of members of the Company in respect of the joint shareholding.

6. Shareholders who attend the meeting in person or by proxy shall bear their own travelling and accommodation expenses.

7. A Shareholder or his/her proxy should produce proof of identity when attending the H Share Class Meeting.

8. Notes for the meeting:

If Shareholders attend the meeting on-site, please pay attention to the following matters:

• (1) Please contact the Office of the Board of the Company no later than two days before the convening of the H Share Class Meeting (i.e. before 10:00 a.m. on Saturday, August 13, 2022), and complete the declaration of personal health information, including their basic personal information, epidemiological history screening, health monitoring condition, and vaccination status. In order to protect the health of the attendees, Shareholders who have not completed the declaration within the aforesaid time, or have travelled to medium- to high-risk areas in recent 14 days, or do not meet the pandemic prevention requirements will not be able to enter the venue of the general meeting.

• (2) Upon arrival at the meeting venue on the day of the H Share Class Meeting, please cooperate with the implementation of the epidemic prevention and control requirements such as registration for meeting attendance, health information query and confirmation, and temperature detection, and strictly abide by the epidemic prevention regulations of local government. Please wear a mask at all times during the meeting and keep necessary distance according to the meeting arrangement.

– 2 –

• (3) Contact information of the meeting:

The Office of the Board of Jiangsu Recbio Technology Co., Ltd. Address: Room A109, Vaccine Engineering Centre, China Medical City, Taizhou City, Jiangsu Province Postal code: 225300 Phone: (0523) 8882 0888 Email: ir@recbio.cn

1. Further details of the resolutions are set out in the circular of the Company dated July 29, 2022.

2. References to dates and time in this notice are to Hong Kong dates and time.

As at the date of this notice, the Board of the Company comprises Dr. LIU Yong as the chairman of the Board and an executive Director, Dr. CHEN Jianping and Mr. LI Bu as executive Directors, Dr. HONG Kunxue, Dr. ZHOU Hongbin, Mr. ZHAO Hui, Dr. DU Wei and Dr. FENG Tao as non-executive Directors, and Mr. LIANG Guodong, Dr. XIA Lijun, Professor GAO Feng and Professor YUEN Ming Fai as independent non-executive Directors.

– 3 –